By physician referral or invitation only

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

To assess the effects of intervention on histologic disease activity following 12 weeks of treatment

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina

Additional Study Information

Principal Investigator

Hans Herfarth
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Stomach, Digestion and Gut Health

IRB Number

25-2081

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

My UNC Chart
Find a Doctor
Accessibility
Privacy Policy
For Researchers

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.